Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    12385448 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Development of a Breath Test for Monitoring Patients With Liver Disease
Conditions: Fatty Liver;   Cirrhosis
Interventions: Drug: 13C-Methacetin;   Device: Breath ID Machine
2 Unknown  Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium
Condition: Hepatic Fibrosis
Intervention: Procedure: MRI of liver

Indicates status has not been verified in more than two years